$FSDC Gemini Therapeutics, Inc. /DE Insider Trading
Get free email notifications about insider trading in Gemini Therapeutics, Inc. /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Gemini Therapeutics, Inc. /DE. Insider overview, share value development, latest insider transactions and email notifications about new events in Gemini Therapeutics, Inc. /DE for free.
CIK Number: 0001816736
IRS Number: 851613057
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FSDC
Company Address: 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE 02139
Former name: FS Development Corp., date of change: 2020-07-02
Gemini Therapeutics, Inc. /DE Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | FSDC | Gemini Therapeutic ... | GEMAYEL GEORGES | Director | Option Exercise | A | 11.92 | 45,466 | 541,955 | 45,466 | |
May 03 2021 | FSDC | Gemini Therapeutic ... | Strapps Walter | Chief Scientific Of ... | Option Exercise | A | 11.92 | 9,000 | 107,280 | 9,000 | |
Apr 14 2021 | FSDC | Gemini Therapeutic ... | Piekos Brian | Chief Financial Off ... | Option Exercise | A | 12.59 | 377,734 | 4,755,671 | 377,734 | |
Apr 14 2021 | FSDC | Gemini Therapeutic ... | Barone Samuel B. | Chief Medical Offic ... | Option Exercise | A | 12.59 | 255,212 | 3,213,119 | 255,212 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Strapps Walter | Chief Scientific Of ... | Option Exercise | A | 12.66 | 79,094 | 1,001,330 | 79,094 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Ong Tuyen | Director | Option Exercise | A | 12.66 | 58,855 | 745,104 | 58,855 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Lubner David Charles | Director | Option Exercise | A | 12.66 | 58,855 | 745,104 | 58,855 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Uknis Marc | Chief Medical Offic ... | Option Exercise | A | 12.66 | 277,117 | 3,508,301 | 277,117 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Meyenburg Jason Patrick | President & CEO | Option Exercise | A | 12.66 | 1,124,832 | 14,240,373 | 1,124,832 | |
Apr 07 2021 | FSDC | Gemini Therapeutic ... | Lauder Scott | Chief Technology Of ... | Option Exercise | A | 12.66 | 243,996 | 3,088,989 | 243,996 | |
Mar 15 2021 | FSDC | Gemini Therapeutic ... | Ong Tuyen | Director | Option Exercise | A | 17.00 | 15,000 | 255,000 | 15,000 | |
Mar 15 2021 | FSDC | Gemini Therapeutic ... | Lubner David Charles | Director | Option Exercise | A | 17.00 | 25,000 | 425,000 | 25,000 | |
Feb 25 2021 | FSDC | Gemini Therapeutic ... | Redmond Precillia | Chief People Office ... | Option Exercise | A | 14.21 | 25,489 | 362,199 | 25,489 | |
Feb 25 2021 | FSDC | Gemini Therapeutic ... | Lauder Scott | Chief Technology Of ... | Option Exercise | A | 14.21 | 272,615 | 3,873,859 | 272,615 | |
Feb 09 2021 | FSDC | Gemini Therapeutic ... | Tananbaum James B. | Director | Option Exercise | C | 0.00 | 2,928,750 | 0 | 0 |
View all Gemini Therapeutics, Inc. /DE insider transactions.